Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption

Journal of the Neurological Sciences

Volumn 157, Issue 1, 1998, Pages 90-95

  Tagawa, Yumi ^a,b   Yuki, Nobuhiro ^a   Hirata, Koichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Anti ganglioside antibody; Double filtration plasmapheresis; Fisher's syndrome; Guillain Barre syndrome; Immunoadsorption; Plasma exchange

Indexed keywords

GANGLIOSIDE ANTIBODY;

ARTICLE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOADSORPTION; MAJOR CLINICAL STUDY; PLASMAPHERESIS; PRIORITY JOURNAL; SUBCLAVIAN STEAL SYNDROME; TREATMENT OUTCOME;

ADULT; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; IMMUNOSORBENT TECHNIQUES; MALE; PLASMA EXCHANGE; PLASMAPHERESIS;

EID: 0032522338     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00067-7     Document Type: Article

References (35)

1. Agishi T. Technical aspects of double filtration plasmapheresis. Plasma Ther. Transfus. Technol. 4:1983;397-404.
2. Arasaki K., Kusunoki S., Kudo N., Kanazawa I. Acute conduction block in vitro [sic] following exposure to antiganglioside sera. Muscle Nerve. 16:1993;587-593.
3. Arnason BGW, Soliven B. Acute inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral Neuropathy, 3rd ed. Philadelphia: Saunders, 1993:1437-97.
4. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27:1990;S21-S24.
5. Aspinall G.O., McDonald A.G., Pang H., Kurjanczyk L.A. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry. 33:1994;241-249.
6. Bocchi V. Interleukins: clinical pharmacokinetics and practical considerations. Clin. Pharmacokin. 21:1991;274-284.
7. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 43:1993;1911-1917.
8. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann. Neurol. 22:1987;753-761.
9. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome Plasma exchange in Guillain-Barré syndrome: one-year follow-up. Ann. Neurol. 32:1992;94-97.
10. Hartung H.P., Reiners K., Schmidt B., Stoll G., Toyka K.V. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann. Neurol. 30:1991;48-53.
11. Illa I., Ortiz N., Gallard E., Juarez C., Grau J.M., Dalakas M.C. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann. Neurol. 38:1995;218-224.
12. Keller A.J., Chirnside A., Urbaniak S.J. Coagulation abnormalities produced by plasma exchange on the cell separator with special reference to fibrinogen and platelet levels. Br. J. Haematol. 42:1979;593-603.
13. Kornberg A.J., Pestronk A., Bieser K., Ho T.W., McKhann G.M., Wu H.S., Jiang Z. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann. Neurol. 35:1994;234-237.
14. Landi G., D'Alessando R., Dossi B.C., Ricci S., Simone I.L., Ciccone A. Guillain-Barré syndrome after exogenous gangliosides in Italy. Br. Med. J. 307:1993;1463-1464.
15. Latov N., Koski C.L., Walicke P.A. Guillain-Barré syndrome and parenteral ganglioside. Lancet. 338:1991;757.
16. Mestecky J., McGhee J.R. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:1987;153-245.
17. Orlin J.B., Berkman E.M. Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents. Blood. 56:1980;1055-1059.
18. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group Randomized trial of plasma exchange, intravenous immunoglobulin and combined treatments in Guillain-Barré syndrome. Lancet. 349:1997;225-230.
19. Reimann P.M., Mason P.D. Plasmapheresis: technique and complications. Intensive Care Med. 16:1990;3-10.
20. Roberts M., Willison H.J., Vincent A., Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann. Neurol. 37:1995;436-442.
21. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: F.A. Davis, 1991.
22. Santoro M., Uncini A., Corbo M., Staygaitis S.M., Thomas F.P., Hays A.P., Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann. Neurol. 31:1992;385-390.
23. + currents in isolated rat myelinated nerve fibers. Ann. Neurol. 37:1995;436-442.
24. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Appropriate number of plasma exchanges in Guillain-Barré syndrome. Ann. Neurol. 41:1997;298-306.
25. The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology. 35:1985;1096-1104.
26. Thornton C.A., Griggs R.C. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann. Neurol. 35:1994;260-268.
27. the Dutch Guillain-Barré Study Group, van der Meché F.G.A., Schmitz P.I.M. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl. J. Med. 326:1992;1123-1129.
28. the Dutch Guillain-Barré Study Group, Visser L.H., van der Meché F.G.A., van Doorn P.A., Meulstee J., Jacobs B.C., Oomes P.G., Kleyweg R.P. Guillain-Barré syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain. 118:1995;841-847.
29. Waldermann T.A., Strober W. Metabolism of immunoglobulins. Prog. Allergy. 13:1969;1-110.
30. Walsh F.S., Cronin M., Koblar S., Doherty P. Association between glycoconjugate antibodies and Campylobacter [sic] infection in patients with Guillain-Barré syndrome. J. Neuroimmunol. 34:1991;43-51.
31. Wirguin I., Suturkova-Milosevic L.J., Della-Latta P., Fisher T., Brown R.H., Latov N. Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides. Ann. Neurol. 35:1994;698-703.
32. Wood L., Jacobs P. The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levels. J. Clin. Apheresis. 3:1986;124-128.
33. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178:1993;1771-1775.
34. Yuki N. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: a new approach to treatment. Neurology. 46:1996;1644-1651.
35. Yuki N., Tagawa Y., Irie F., Hirabayashi Y., Handa S. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α J. Neuroimmunol. 74:1997;30-34.